Commerce Bank Novo Cure LTD Transaction History

Commerce Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$56.44 - $118.81 $1,241 - $2,613	22 Added 0.52%	4,285 $257,000
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $4,606 - $6,146	72 Added 1.72%	4,263 $312,000
Q3 2022 Nov 04, 2022	BUY	$67.99 - $89.57 $12,034 - $15,853	177 Added 4.41%	4,191 $318,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $11,546 - $18,339	-204 Reduced 4.84%	4,014 $279,000
Q1 2022 May 09, 2022	BUY	$60.15 - $84.52 $253,712 - $356,505	4,218 New	4,218 $349,000
Q3 2021 Nov 09, 2021	SELL	$116.17 - $194.55 $271,837 - $455,247	-2,340 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$130.4 - $225.58 $15,387 - $26,618	118 Added 5.31%	2,340 $519,000
Q1 2021 May 05, 2021	BUY	$124.11 - $190.17 $32,640 - $50,014	263 Added 13.43%	2,222 $294,000
Q4 2020 Feb 09, 2021	BUY	$112.16 - $174.14 $219,721 - $341,140	1,959 New	1,959 $339,000

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

Stay updated on Commerce Bank with notifications on news.